Two years ago, AbbVie ranked 13th on the market, but a hepatitis drug took it to a 7.8% market share in July 2015- June 2016 and helped it become the leading pharmaceutical company in Romania.
Sanofi was market leader for five years, with Hoffmann La Roche interrupting its reign for one year, ZF has found from market research company Cegedim’s quarterly reports.
AbbVie’s performance is because of the reimbursement by the National Health Insurance House of the medication necessary for treating chronic viral hepatitis. The Viekirax brand, which became available in Romania in May 2015, boosted AbbVie’s sales to almost one billion lei in July 2015-June 2016.
French-held Sanofi ranked second, with a market share of 6.8%, while Switzerland’s Novartis ranked third, with 4.9% market share, according to Cegedim’s survey, which took into account the sales of the pharmaceutical companies in July 2015 – June 2016.
The top ten also includes French-held Servier, US-held Pfizer and Indian-held SunPharma. The top ten pharmaceutical companies account for 47% of the total market.
(English version by Loredana Fratila-Cristescu)